Securities code: Hubei Biocause Pharmaceutical Co.Ltd(000627) securities abbreviation: Hubei Biocause Pharmaceutical Co.Ltd(000627) Announcement No.: 202222
Hubei Biocause Pharmaceutical Co.Ltd(000627)
First quarter report 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Important content tips: 1 The board of directors, the board of supervisors, directors, supervisors and senior managers guarantee that the quarterly report is true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities. 2. The person in charge of the company, the person in charge of accounting and the person in charge of the accounting organization (Accounting Supervisor) declare that they guarantee the authenticity, accuracy and completeness of the financial information in the quarterly report. 3. Whether the first quarter report has been audited □ yes √ No 1. Main financial data (I) whether the company needs to retroactively adjust or restate the accounting data of previous years □ yes √ no
Increase or decrease in the reporting period compared with the same period of the previous year
Operating income (yuan): 1821499 Shenzhen L&A Design Holding Limited(300949) 1275804322203 42.77%
Net profit attributable to shareholders of listed company (yuan): 1472954181622451364589 – 34.39%
Net profit attributable to shareholders of listed companies after deducting non recurring profits and losses of 15011138068, 20052247393 – 25.14% (yuan)
Net cash flow from operating activities (yuan) -417773656392168499069861 -347.94%
Basic earnings per share (yuan / share) 0.03 0.0454 – 33.92%
Diluted earnings per share (yuan / share) 0.03 0.0454 – 33.92%
Weighted average return on net assets: 0.67%, 1.05% – 0.38%
Increase or decrease at the end of the reporting period compared with the end of the previous year
Total assets (yuan) 2685999513680226390396577601 1.78%
Owner’s equity attributable to shareholders of listed companies 21620664637712255333382941 – 4.14% (yuan)
（2） □ amount of non recurring items and inapplicability
Unit: Yuan
Description of the amount of the project in the current reporting period
Gains and losses on disposal of non current assets (including write off department with provision for asset impairment) 25483418
(sub) government subsidies included in current profits and losses (closely related to the company’s normal business,
418185388 in line with national policies and regulations and continuously enjoyed in accordance with certain standards, quotas or quotas
Except for government subsidies), except for the effective hedging business related to the normal business of the company, the
Profit and loss from changes in fair value of trading financial assets and trading financial liabilities, 0.00
And the investment income obtained from the disposal of trading financial assets, trading financial liabilities and available for sale financial assets
Other non operating income and expenditure other than the above -1180839179
Less: income tax impact -184292593
Influence amount of minority shareholders’ equity (after tax) -271281528
Total -281596252–
Details of other profit and loss items that meet the definition of non recurring profit and loss: □ applicable √ not applicable. The company does not have details of other profit and loss items that meet the definition of non recurring profit and loss.
Description of defining the non recurring profit and loss items listed in the explanatory announcement on information disclosure of companies offering securities to the public No. 1 – non recurring profit and loss as recurring profit and loss items □ applicable √ not applicable the company does not define the non recurring profit and loss items listed in the explanatory announcement on Information Disclosure of companies offering securities to the public No. 1 – non recurring profit and loss as recurring profit and loss items. （3） Changes and reasons of main accounting data and financial indicators √ applicable □ not applicable I. balance sheet items
Reasons for the increase / decrease ratio of the project at the end of the reporting period and the end of the previous year
example
Purchase of resale financial assets 36414012910239928448665 – 84.82 time point factors
Accounts receivable 47740264422874415910 66.09 new accounts receivable in the reporting period
Premium receivable 3916172256959243924869 – 33.90 time point factor
Other receivables 455107357418295560819115 53.98 increase in investment receivables during the reporting period
Reinsurance accounts receivable 2903642218017993108727 61.38 reinsurance business factors
Deferred income tax assets 178100188237101030841069 76.28 fair value of available for sale financial assets
Impact of value change
Advance premium 1330685073423560655252 -43.52 time point factor
Financial assets sold for repurchase 16983374 China Baoan Group Co.Ltd(000009) 42576800000 80.18 time point factor
Reinsurance accounts payable 3065244836920687096902 48.17 reinsurance business factors
Payroll payable 992593268218738001130 – 47.03 time point factors
Tax payable 647194884114253836492 – 54.60 time point factor
Policy dividend payable 2128965863713440282088 58.40 time point factor
Contract liabilities 1113137622793613812 40.26 sales advances
Other liabilities 289243509458135216267 255.54 accrued bond interest payable
Other comprehensive income -109506841438 -1510380452 -715028 fair value of available for sale financial assets
Impact of value change
2、 Income statement items
Reasons for the increase / decrease ratio of the project in the same period of last year in the reporting period
example
Operating income 1821499 Shenzhen L&A Design Holding Limited(300949) 1275804322203 42.77 increase in premium income
Earned premium 1518477646612990896991197 53.24 premium income increased
Reinsurance income 108533075037161134582 51.56 reinsurance business factors
Ceded premium 132142158439598251701 – 96.66 reinsurance business factors
Income from changes in fair value -40792680950 -22065203739 -84.87 impact of capital market fluctuations
Surrender money 1694179911354659328392745 156.96 insurance product term impact
Amortized reinsurance surrender fund 5966750115382442701 -88.91 reinsurance business factors
Withdrawal of insurance liability reserve -192112874856294725399737 -165.18 impact on business structure
Amortized insurance liability reserve 641274742 -39456065314 101.63 reinsurance business factors
Policy dividend expenditure 9819840900 Suzhou Xingye Materials Technology Co.Ltd(603928) 764152599 policy dividend expenditure withdrawn
Amortized reinsurance expense 294165333538191679
